U.S. Endoscopes Market to Reach USD 12.09B by 2035

Market Outlook

By 2035, the U.S. Endoscopes Market is expected to reach approximately USD 12.09 billion, expanding at compound annual growth rate of 8.82% during the forecast period from 2026 to 2035. The market was valued at approximately USD 5.19 billion in 2025, following historical expansion from an estimated USD 3.65 billion in 2021 to USD 4.77 billion in 2024. Values in this report are expressed in USD billions.

This report defines the U.S. endoscopes market as revenue generated from reusable flexible endoscopes, rigid endoscopes, single-use endoscopes, capsule endoscopes, ultrasound-enabled endoscopes and robotic or navigation-assisted endoscopic platforms sold within the United States. Standalone video processors, light sources, insufflators, reprocessing equipment, surgical accessories and procedure-service revenue are excluded except where their integration directly influences endoscope procurement.

The U.S. endoscopes industry occupies a strategically important position within the medical device market because endoscopic visualization is embedded across gastroenterology, pulmonology, urology, gynecology, otolaryngology, general surgery, orthopedics and neurosurgery. Endoscopes allow clinicians to screen for disease, inspect anatomical structures, collect tissue, remove lesions, control bleeding, extract stones, perform minimally invasive surgery and guide complex therapeutic interventions without relying on large surgical incisions.

Demand is supported by a large and recurring procedure base. Approximately 15 million colonoscopies are performed annually in the United States, while millions of upper gastrointestinal endoscopies, bronchoscopies, cystoscopies, ureteroscopies, hysteroscopies, laparoscopies, arthroscopies and ENT examinations create additional utilization. Colorectal screening recommendations beginning at age 45 have widened the eligible population, while the continued use of colonoscopy for surveillance and follow-up after abnormal stool-based tests protects long-term procedure demand.

The disease burden supporting endoscope utilization is substantial. An estimated 154,270 new colorectal cancer cases, 226,650 lung and bronchus cancer cases, 84,870 bladder cancer cases, 59,660 oral cavity and pharyngeal cancer cases and 13,360 cervical cancer cases were expected in the United States in 2025. Endoscopes are also used for non-cancer conditions including inflammatory bowel disease, gastroesophageal reflux disease, gastrointestinal bleeding, biliary obstruction, kidney stones, benign prostatic enlargement, chronic sinus disease, uterine abnormalities, endometriosis, joint injuries and pulmonary nodules.

The market is progressing from conventional reusable visualization instruments toward a more differentiated ecosystem built around high-definition and 4K imaging, extended depth of field, optical enhancement, endoscopic ultrasound, disposable scopes, AI-assisted lesion detection, robotic bronchoscopy and integrated clinical data. Hospitals and ambulatory facilities are increasingly evaluating endoscope platforms according to diagnostic yield, procedure throughput, infection-control economics, repair frequency, training requirements, compatibility with installed systems and total cost per completed procedure.

Historical growth accelerated after procedure volumes recovered from pandemic-era disruption. The market increased from approximately USD 3.65 billion in 2021 to USD 4.05 billion in 2022 and USD 4.43 billion in 2023. It reached about USD 4.77 billion in 2024 as health systems resumed capital replacement, ambulatory endoscopy networks expanded and manufacturers introduced new single-use and digitally enabled products. Revenue advanced to USD 5.19 billion in 2025 as demand strengthened for premium GI imaging, disposable urology and pulmonary scopes, AI-compatible colonoscopes and robotic endoluminal systems.

Introduction

According to the U.S. Endoscopes Market Report, endoscopy has evolved from a visualization function into an integrated diagnostic and therapeutic service line. Modern endoscopes are expected to provide image clarity, ergonomic control, access to difficult anatomy, compatibility with instruments, reliable suction and irrigation, digital documentation and connectivity with hospital information systems. The competitive value of a scope is therefore determined not only by optics but also by its contribution to clinical workflow and procedural economics.

The U.S. market has a broad care-delivery foundation. The country has more than 6,000 hospitals, over 900,000 staffed hospital beds and approximately 6,400 Medicare-certified ambulatory surgery centers. Endoscopy is delivered through hospital outpatient departments, inpatient procedural units, dedicated GI centers, multispecialty ambulatory surgery centers, physician-owned facilities, pulmonary laboratories, urology practices, ENT clinics and office-based procedure rooms. This diversity creates different purchasing requirements across capital-intensive reusable platforms and lower-infrastructure single-use solutions.

Large hospitals and academic medical centers generally maintain broad reusable fleets because they perform high volumes of advanced procedures and can spread capital and reprocessing costs across many cases. These facilities frequently standardize around major video platforms and negotiate multi-year agreements covering scopes, processors, service, repairs, reprocessing compatibility and clinical training. Smaller hospitals, rural facilities and office-based practices may prefer single-use scopes for lower-volume applications where capital ownership and reprocessing infrastructure are less economical.

Flexible endoscopes generate the largest share of the market because of their use in gastrointestinal, pulmonary, urological and upper-airway procedures. Rigid endoscopes remain essential in laparoscopy, arthroscopy, hysteroscopy, cystoscopy, ENT surgery and selected neurosurgical applications. Single-use scopes are expanding rapidly in bronchoscopy, urology and ENT, with adoption increasingly influenced by infection prevention, immediate availability and the avoidance of repair or reprocessing delays.

The market is also closely linked to U.S. reimbursement and site-of-care economics. Hospitals must justify premium systems through increased procedural capacity, improved lesion detection, reduced repeat examinations, lower complications and stronger referral capture. Ambulatory facilities focus more heavily on rapid room turnover, predictable case cost, equipment uptime, lower labor burden and compatibility across physicians. Manufacturers that understand these differences are better positioned to design segmented commercial, service and contracting strategies.

From 2026 through 2035, the central strategic shift will be from instrument-centered purchasing toward connected endoscopy ecosystems. Endoscopes will increasingly be evaluated as part of systems that combine visualization, AI support, therapeutic capability, data capture, quality measurement, asset management and infection-control documentation. Companies that can improve both clinical performance and operational productivity will command stronger positions than vendors competing primarily on acquisition price.

Key Market Drivers: What’s Fueling the U.S. Endoscopes Market Boom?

The first major driver is the scale of gastrointestinal screening and disease management. The United States performs approximately 15 million colonoscopies annually, creating one of the largest recurring endoscope-utilization pools globally. Screening recommendations beginning at age 45 increase the number of adults entering colorectal cancer prevention pathways. Positive stool-based screening results also require diagnostic colonoscopy, preserving demand even as non-invasive screening tests gain acceptance.

The 2025 colorectal cancer burden of approximately 154,270 new cases and 52,900 deaths reinforces the clinical importance of screening, surveillance and polypectomy. Colorectal cancer can develop from precancerous polyps, allowing endoscopy to play both a diagnostic and preventive role. This differentiates colonoscopy from many imaging procedures because a lesion can be identified, sampled and removed during the same episode.

A second driver is the transition toward minimally invasive diagnosis and treatment. Endoscopes enable procedures through natural orifices or small incisions, supporting shorter recovery, lower tissue disruption and reduced hospitalization compared with open surgery. Ureteroscopy, hysteroscopy, laparoscopy, arthroscopy, endoscopic sinus surgery, bronchoscopy and therapeutic GI endoscopy are aligned with payer and provider efforts to shift suitable care toward outpatient settings.

A third driver is the rising prevalence of cancers and chronic diseases requiring endoscopic evaluation. The United States recorded an estimated 226,650 new lung and bronchus cancer cases in 2025. Greater detection of pulmonary nodules through low-dose CT screening is supporting demand for advanced bronchoscopes, endobronchial ultrasound and robotic navigation platforms capable of reaching peripheral lung lesions.

Bladder cancer contributes another recurring demand base, with approximately 84,870 new U.S. cases estimated in 2025. Cystoscopy remains central to initial evaluation and repeated surveillance because bladder tumors have a high risk of recurrence. Kidney stones, ureteral obstruction and upper urinary tract disorders further expand demand for cystoscopes, ureteroscopes and nephroscopes.

A fourth driver is the expansion of ambulatory endoscopy capacity. The United States had approximately 6,436 Medicare-certified ambulatory surgery centers in 2024, with the number of facilities and procedure volumes continuing to rise. Gastrointestinal procedures are among the most established ASC service lines because they are scheduled, repeatable and suitable for high-throughput workflows. Increased migration toward ambulatory facilities supports demand for reliable reusable fleets, compact systems, single-use scopes and service models that minimize procedural disruption.

A fifth driver is infection prevention and greater scrutiny of reusable-device reprocessing. Flexible endoscopes have narrow channels, complex components and surfaces that can be difficult to clean when procedures or device designs are highly complex. FDA recommendations encouraging healthcare facilities to transition away from fixed-endcap duodenoscopes toward disposable components or fully disposable alternatives have influenced the direction of product development across the broader endoscopy industry.

Infection-control economics extend beyond the purchase price of a scope. Facilities must consider labor, detergents, automated reprocessor use, water and electricity, drying, storage, microbiological surveillance, staff training, documentation and the consequences of incomplete reprocessing. Single-use products are gaining adoption when the avoided reprocessing cost, increased availability and reduced contamination risk offset a higher per-procedure acquisition cost.

A sixth driver is the replacement of aging installed equipment. Many U.S. hospitals purchased high-definition endoscopy platforms during earlier capital cycles and are now evaluating 4K imaging, extended depth of field, optical enhancement, AI integration and improved ergonomics. Replacement decisions are often made at the platform level because scope compatibility, processor capabilities and service contracts are tightly connected.

A seventh driver is the emergence of AI-assisted endoscopy. Computer-aided detection systems can analyze live colonoscopy video and alert clinicians to potential lesions. AI does not replace physician judgment, but it can improve consistency, support quality measurement and reduce variation between operators. As AI becomes integrated into processors and scope ecosystems, hospitals may accelerate upgrades to maintain competitiveness and meet physician expectations.

An eighth driver is specialist demand for better access to difficult anatomy. Robotic bronchoscopy, steerable catheters, improved distal-tip control, smaller diameters and enhanced working channels are enabling physicians to reach lesions that are difficult to access with conventional devices. This is particularly relevant for peripheral pulmonary nodules, complex biliary disease, upper urinary tract conditions and advanced endoluminal interventions.

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the U.S. endoscopes market is moving toward improved visualization, broader therapeutic capability, reduced infection risk and more efficient procedure execution. Manufacturers are no longer competing solely on resolution. They are developing integrated systems intended to help clinicians detect disease earlier, navigate anatomy more effectively, document quality and perform advanced therapy during the same procedure.

High-definition and 4K visualization remain foundational innovation areas. Improved pixel density, image processing, illumination and display quality can provide better views of mucosal and vascular patterns. Extended depth-of-field technologies are designed to keep a wider portion of the endoscopic field in focus, reducing the need for constant focal adjustment and supporting consistent visualization during movement.

Optical enhancement is becoming increasingly important in GI and ENT endoscopy. Technologies based on filtered light, wavelength selection, contrast enhancement and digital processing can improve the visibility of vascular and mucosal structures. Their commercial value depends on whether they improve lesion characterization, support targeted biopsy and fit naturally into physician workflow without materially increasing procedure time.

AI-assisted lesion detection represents a major competitive cycle. In 2024, the FDA cleared additional computer-assisted detection solutions for colonoscopy, increasing competition beyond early market entrants. U.S. providers can now evaluate multiple platforms based on detection performance, compatibility, workflow, subscription economics, data ownership and integration with installed endoscopy equipment.

The next stage of AI will extend beyond drawing a box around a suspected polyp. Future systems are expected to support lesion characterization, bowel-preparation assessment, withdrawal-time measurement, blind-spot identification, automated documentation and quality dashboards. AI may also become more relevant in upper GI, inflammatory bowel disease, capsule endoscopy, pulmonary imaging and ENT applications.

Single-use endoscopy is another defining innovation area. Disposable bronchoscopes have achieved meaningful acceptance in intensive care, emergency and operating-room settings because they can be available immediately and eliminate reprocessing between cases. The category is expanding into cystoscopy, ureteroscopy, nephroscopy, gastroscopy and rhinolaryngoscopy as manufacturers improve image quality, ergonomics and accessory compatibility.

The economic case for single-use products varies by procedure volume and facility type. High-volume centers may achieve low per-procedure costs with reusable fleets, while lower-volume or decentralized settings can face high fixed reprocessing and repair costs. Hybrid fleets are therefore becoming common, with reusable scopes used for high-volume scheduled procedures and single-use scopes reserved for after-hours cases, isolation patients, overflow capacity or applications with difficult reprocessing requirements.

Robotic and navigation-assisted endoscopy is expanding in pulmonary medicine. Robotic bronchoscopy platforms combine pre-procedure imaging, computerized pathways and highly steerable catheters to reach peripheral lung nodules. Continued integration of AI and advanced imaging is designed to address differences between preoperative CT anatomy and the position of the lung during the procedure.

Endoscopic ultrasound is also advancing. EUS and EBUS combine endoscopic access with ultrasound imaging to evaluate structures beyond the luminal surface. They are used in pancreatic, biliary, gastrointestinal and pulmonary disease, including tissue acquisition and staging. Platforms capable of supporting GI and pulmonary ultrasound on a common workstation can improve asset utilization for hospitals with multidisciplinary endoscopy programs.

Manufacturers are also improving ergonomics and durability. Flexible endoscope operation can contribute to repetitive strain among clinicians, while frequent bending and handling can create repair requirements. Lighter control bodies, optimized button placement, improved torque response, better insertion-tube flexibility and more durable distal components can influence purchasing decisions even when image quality is comparable.

Connectivity is becoming an important differentiator. Endoscopy systems increasingly interface with electronic medical records, picture archiving, procedure documentation, quality reporting and asset-management platforms. Automated transfer of images, procedural information and quality metrics can reduce manual work and improve data consistency.

Segmentation Insights

The U.S. Endoscopes Market is segmented on the basis of product category, application, end user, technology type and region.

By Product Category

Reusable flexible endoscopes represented the largest product category in 2025, accounting for an estimated 47% of market revenue, or approximately USD 2.44 billion. This category includes colonoscopes, gastroscopes, duodenoscopes, bronchoscopes, cystoscopes, ureteroscopes, choledochoscopes, rhinolaryngoscopes and specialty flexible scopes. Their leadership is supported by large procedure volumes, strong physician familiarity and integration with established video platforms.
Reusable flexible scopes remain economically attractive in high-volume facilities that have trained reprocessing teams and can maintain sufficient fleet utilization. Their value is highest when advanced imaging, therapeutic working channels and premium maneuverability are required. However, repair expenses, scope availability and infection-control requirements are prompting providers to improve fleet management and evaluate hybrid reusable-disposable strategies.
Rigid endoscopes form a mature but durable category used in laparoscopy, arthroscopy, hysteroscopy, cystoscopy, ENT surgery and neurosurgery. Rigid scopes provide high-quality optical performance, mechanical stability and compatibility with surgical instruments. Demand is supported by recurring replacement, operating-room expansion and adoption of minimally invasive surgery across hospital and ambulatory settings.
Laparoscopes represent an important rigid subsegment because they are used across general, gynecological, bariatric, colorectal and urological surgery. Arthroscopes are supported by high orthopedic procedure volumes and outpatient migration. Sinuscopes, hysteroscopes and rigid cystoscopes provide additional recurring demand from specialty surgical departments.
Single-use endoscopes are expected to record the fastest product growth through 2035. The category includes disposable bronchoscopes, cystoscopes, ureteroscopes, nephroscopes, gastroscopes and ENT scopes. Growth is being driven by infection prevention, immediate availability, elimination of repair downtime and suitability for decentralized or low-volume care settings.
Single-use devices are increasingly evaluated through complete cost-per-case models. Buyers assess purchase price against reprocessing labor, chemicals, utilities, capital depreciation, maintenance, repair, transport and the cost of cancelled procedures. Adoption will be strongest where disposable products achieve clinically acceptable visualization and maneuverability without creating excessive waste-management or supply-chain burden.
Capsule endoscopes provide non-invasive visualization of the gastrointestinal tract, particularly the small bowel. They are used in obscure GI bleeding, suspected Crohn’s disease and selected cases where conventional endoscopy is incomplete or unsuitable. Capsule systems include the ingestible camera, data recorder and interpretation software.
AI-assisted image review can reduce the time required to analyze thousands of capsule images, improving the scalability of the category. Capsule endoscopy is unlikely to displace therapeutic flexible endoscopy because it cannot routinely biopsy or treat lesions, but it will remain an important complementary diagnostic tool.
Robot-assisted and navigation-enabled endoscopes represent a smaller but premium-value segment. Robotic bronchoscopy is the most commercially advanced application, with systems designed to reach peripheral pulmonary lesions. Future opportunities include robotic GI navigation, flexible endoluminal surgery and systems that reduce the physical burden of scope manipulation.

By Application

Gastrointestinal endoscopy was the largest application in 2025, generating an estimated 51% of market revenue, or approximately USD 2.65 billion. The segment includes colonoscopy, upper GI endoscopy, ERCP, EUS, enteroscopy, sigmoidoscopy and capsule endoscopy. Demand is supported by colorectal cancer screening, gastrointestinal bleeding, reflux disease, inflammatory bowel disease, biliary disorders and pancreatic disease.
Colonoscopy is the central volume driver. The annual U.S. procedure base creates recurring demand for colonoscope replacements, fleet expansion and AI-compatible systems. Upper GI endoscopy contributes substantial additional volume, while EUS and ERCP create premium demand for specialized scopes used in high-acuity diagnostic and therapeutic procedures.
Laparoscopy and general surgery represent a major application for rigid endoscopes. Laparoscopes are used in gallbladder removal, hernia repair, appendectomy, bariatric surgery, colorectal surgery and other abdominal procedures. Growth is linked to outpatient migration, improvements in minimally invasive instruments and demand for high-resolution surgical imaging.
Hospitals frequently purchase laparoscopic scopes as part of broader operating-room visualization platforms. Procurement is influenced by image quality, camera compatibility, sterilization requirements, repair turnaround and the ability to use a common platform across multiple specialties.
Urology endoscopy includes cystoscopy, ureteroscopy, nephroscopy and related procedures for bladder tumors, kidney stones, obstruction and urinary tract abnormalities. The estimated 84,870 new bladder cancer cases in 2025 create recurring cystoscopic surveillance demand, while kidney-stone prevalence supports ureteroscopy.
Single-use urology scopes are gaining traction because reusable ureteroscopes are delicate and can be expensive to repair. The most attractive disposable platforms will be those that deliver reliable deflection, adequate working-channel performance and strong image quality during complex stone procedures.
Bronchoscopy and pulmonary endoscopy are expanding due to lung-cancer screening, pulmonary nodule detection and the need for tissue diagnosis. The 2025 burden of approximately 226,650 new lung cancer cases creates a significant clinical need for earlier and more accurate diagnosis.
Conventional flexible bronchoscopy remains widely used in airway evaluation, secretion management, biopsy and critical care. EBUS and robotic bronchoscopy add premium growth by enabling lymph-node staging and access to peripheral lesions. Single-use bronchoscopes are particularly relevant in emergency, ICU and infection-isolation workflows.
Gynecology, ENT, orthopedics and neuroendoscopy collectively provide a diversified application base. Hysteroscopes support diagnosis and treatment of abnormal uterine bleeding, polyps and fibroids. Sinuscopes and rhinolaryngoscopes are used in ENT surgery and office examinations. Arthroscopes are important in knee, shoulder, hip and small-joint procedures, while neuroendoscopes support selected minimally invasive cranial and spinal interventions.

By End User

Hospitals and integrated health systems were the dominant end users in 2025, contributing approximately 48% of market revenue, or about USD 2.49 billion. Hospitals perform the broadest range of diagnostic, therapeutic and surgical endoscopic procedures and account for most complex ERCP, EUS, robotic bronchoscopy, advanced laparoscopy and inpatient endoscopy.
Large health systems increasingly negotiate enterprise agreements. These contracts may cover multiple hospitals, service support, repairs, loaner scopes, software, clinical training and capital upgrades. Vendor standardization can reduce complexity but makes competitive displacement difficult once a system has committed to a major platform.
Hospital procurement committees assess whether a new endoscope improves clinical capability, supports physician recruitment, reduces procedure time, increases room utilization or prevents cancellations. Infection prevention, cybersecurity, equipment traceability and compatibility with reprocessing systems are also important evaluation criteria.
Ambulatory surgery centers and dedicated endoscopy centers are among the fastest-growing end-user groups. Approximately 6,436 Medicare-certified ASCs were operating in 2024, and gastrointestinal procedures represent a major share of activity in many centers. These facilities prioritize high throughput, predictable cost and minimal downtime.
ASC procurement behavior is highly sensitive to procedure economics. A system that reduces room turnover by several minutes, limits repairs or improves scheduling reliability can generate meaningful value across thousands of annual procedures. Physician owners may also have stronger influence over purchasing than they do within large hospitals.
Specialty clinics and physician offices use endoscopes in urology, ENT, pulmonary and selected GI applications. Office-based cystoscopy and rhinolaryngoscopy create demand for compact systems and disposable scopes that do not require large reprocessing departments. Unsedated transnasal endoscopy may also expand selected pediatric and adult office-based workflows.
Academic medical centers and specialty referral institutions act as early adopters and evidence generators. They perform advanced endoscopic resections, third-space procedures, complex EUS, robotic bronchoscopy and experimental endoluminal interventions. Although their facility count is limited, they influence broader market adoption through training, clinical trials and physician education.
Rural hospitals, community facilities and mobile services represent an important access-oriented segment. Low procedure volumes can make broad reusable fleets difficult to justify, creating opportunities for single-use scopes and compact portable systems. Tele-mentoring and connected imaging may improve access to specialist expertise over the forecast period.

By Technology Type

High-definition, 4K and advanced optical imaging endoscopes account for the largest technology segment. High-definition imaging has become a baseline requirement in most U.S. facilities, while 4K, extended depth of field and enhanced contrast support premium replacement cycles. Adoption depends on the age of installed processors and the clinical case for platform-wide upgrades.
AI-compatible endoscopy systems are expected to experience strong growth through 2035. Computer-aided detection is currently concentrated in colonoscopy, but the commercial opportunity could expand into characterization, quality measurement, upper GI disease, inflammatory bowel disease and capsule analysis.
Hospitals will increasingly compare AI systems according to sensitivity, false-positive burden, workflow integration, update strategy and long-term software cost. AI compatibility can also protect the future value of newly purchased scopes and processors.
Endoscopic ultrasound-enabled systems combine direct visualization with ultrasound imaging. EUS and EBUS scopes are higher-value products requiring specialized training and supporting complex oncology, pancreatic, biliary and pulmonary pathways. Their adoption is concentrated in hospitals and advanced referral centers.
Single-use digital imaging technology is improving rapidly. Earlier disposable scopes were often used when convenience or infection control outweighed image-quality limitations. Newer generations offer stronger resolution, more responsive articulation and compatibility with compact reusable monitors, expanding their role in scheduled procedures.
Robotic, electromagnetic and shape-sensing navigation technology remains a premium emerging category. Robotic bronchoscopy has established the clearest commercial use case, but long-term innovation may enable automated navigation, reduced looping, improved stability and more consistent access in GI and other endoluminal procedures.

Regional Insights: Where the Market is Growing Fastest

The U.S. Endoscopes Market is geographically segmented into the South, West, Northeast and Midwest. Regional performance varies according to population, age distribution, cancer burden, hospital and ASC density, specialist availability, payer mix, screening participation, technology adoption and the concentration of academic medical centers.

The South represented the largest market in 2025, while the West is projected to record the fastest growth through 2035. The Northeast remains the most clinically intensive region for complex and advanced endoscopy, and the Midwest provides a large, stable procedure base supported by mature health systems and strong medical-device infrastructure.

South

The South accounted for an estimated USD 1.82 billion in 2025, representing approximately 35% of the U.S. market. The region is projected to reach about USD 4.31 billion by 2035, supported by population growth, an expanding older adult population, chronic disease prevalence and continued development of hospital and ambulatory capacity.

The region includes Alabama, Arkansas, Delaware, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia and West Virginia, as well as the District of Columbia. Each state presents a different combination of procedure volume, disease burden and infrastructure.

Texas is the largest Southern state market. Houston, Dallas-Fort Worth, Austin and San Antonio contain major health systems, academic centers, cancer programs and extensive ASC networks. The state supports strong demand across GI endoscopy, urology, pulmonary medicine and minimally invasive surgery. Its geographic scale also creates opportunities for portable and single-use devices in community and regional facilities.

Florida is another major demand center because of its large population and high concentration of older adults. The state has significant colonoscopy, cystoscopy, bronchoscopy and upper GI procedure volumes. Health systems in Miami, Orlando, Tampa, Jacksonville and South Florida continue to invest in outpatient endoscopy capacity and advanced diagnostic programs.

North Carolina, Georgia, Tennessee and Virginia are fast-growing markets with expanding metropolitan populations and strong academic or regional referral systems. North Carolina benefits from major research and medical centers in the Research Triangle and Charlotte. Georgia is led by the Atlanta healthcare market, while Tennessee has high-acuity provider hubs in Nashville, Memphis and Knoxville. Virginia combines large integrated systems with proximity to the Washington metropolitan area.

Maryland, Delaware and the District of Columbia have smaller populations but high specialist density and sophisticated medical infrastructure. Institutions in Baltimore and Washington contribute to advanced GI, pulmonary and surgical endoscopy adoption, clinical research and physician training.

Alabama, Mississippi, Louisiana, Kentucky, West Virginia, Arkansas and Oklahoma have meaningful gastrointestinal, pulmonary and metabolic disease burdens. These states also have rural access gaps and fewer advanced specialists outside major cities. Single-use endoscopes, compact visualization systems and regional referral models can address part of this access challenge.

South Carolina is benefiting from population migration and healthcare expansion around Charleston, Columbia, Greenville and Myrtle Beach. Growth is expected in ambulatory GI care, urology and ENT procedures. Across the South, the greatest commercial opportunity will come from balancing premium systems for urban referral centers with scalable, service-efficient technologies for community and rural providers.

West

The West generated an estimated USD 1.20 billion in 2025 and is projected to reach approximately USD 3.05 billion by 2035. It is expected to grow at the fastest regional rate because of technology adoption, population expansion in several states, strong outpatient migration and the concentration of medtech and digital-health innovation.

The region includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington and Wyoming.

California is the largest Western market and one of the most influential endoscopy markets nationally. Los Angeles, San Diego, Orange County, the San Francisco Bay Area and Sacramento contain major academic institutions, integrated systems and high-volume ambulatory networks. The state is an early adopter of AI-assisted imaging, robotic bronchoscopy, advanced endoluminal procedures and connected clinical systems.

California also presents significant variation. Large coastal medical centers support premium technology, while inland and rural communities require cost-efficient equipment and improved specialist access. Manufacturers with broad product portfolios and flexible contracting models can address both market tiers.

Arizona and Nevada are expected to record strong growth because of population expansion and aging demographics. Phoenix, Tucson and Las Vegas are expanding hospital, oncology and outpatient capacity. These markets are attractive for GI screening, urology and pulmonary platforms because providers must add procedural capacity alongside population growth.

Colorado and Utah have sophisticated integrated delivery networks and high adoption of digital clinical technologies. Denver, Salt Lake City and surrounding metropolitan areas support advanced GI, surgical and pulmonary programs. Utah is also important for ambulatory and physician-led specialty care.

Washington and Oregon have mature health systems and strong interest in quality measurement, infection prevention and connected care. Seattle and Portland serve as regional referral centers for advanced endoscopy, while rural communities across both states create opportunities for portable and single-use solutions.

Idaho, Montana, Wyoming, New Mexico and Alaska have smaller populations and long travel distances between specialty centers. Reusable fleets can be difficult to maintain in low-volume sites, strengthening the economic case for disposable bronchoscopy, urology and ENT products. Hawaii has unique logistics and inventory requirements because equipment and replacement components must be supported across islands.

The West’s commercial importance extends beyond procedure volume. Provider organizations in the region frequently participate in technology evaluation, digital-health partnerships and early clinical deployment. As endoscopy becomes more software-enabled, the West is expected to gain national influence.

Northeast

The Northeast accounted for an estimated USD 1.18 billion in 2025 and is forecast to reach approximately USD 2.68 billion by 2035. The region has slower population growth than the South and West but commands high value per procedure because of its concentration of academic medical centers, specialists and complex interventions.

The region includes Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island and Vermont.

New York is the largest Northeast market. New York City and surrounding areas contain high-volume academic hospitals, cancer centers and integrated health networks performing advanced therapeutic GI endoscopy, EUS, ERCP, pulmonary procedures and minimally invasive surgery. Upstate systems in Albany, Buffalo, Rochester and Syracuse add substantial community and referral demand.

Massachusetts has an outsized influence because of its research institutions, academic hospitals and medical-technology ecosystem. Boston providers frequently participate in clinical trials and early evaluation of AI, robotics and advanced endoscopic techniques. Procurement standards are rigorous and often require strong clinical and economic evidence.

Pennsylvania provides a large and diverse procedure base across Philadelphia, Pittsburgh, central Pennsylvania and regional community systems. The state supports high demand for GI screening, pulmonary diagnosis, urology and surgical endoscopy. New Jersey benefits from population density, proximity to New York and Philadelphia, and extensive ambulatory infrastructure.

Connecticut and Rhode Island are mature markets with strong specialist access and health-system consolidation. Maine, New Hampshire and Vermont have older populations but more dispersed care networks. Their rural areas create opportunities for single-use endoscopes and service arrangements that reduce dependence on large reprocessing operations.

The Northeast will remain particularly important for advanced endoscopic resection, third-space endoscopy, interventional EUS, robotic bronchoscopy and clinical evidence development. Buyers generally expect high-quality service support, physician training and detailed health-economic justification.

Midwest

The Midwest represented an estimated USD 0.99 billion in 2025 and is projected to reach approximately USD 2.05 billion by 2035. Growth will be steady rather than speculative, supported by established hospital systems, large community networks, mature screening demand and a strong regional medical-device presence.

The region includes Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota and Wisconsin.

Illinois is the largest Midwestern market, led by Chicago’s extensive academic, community and ambulatory provider ecosystem. The state supports advanced GI endoscopy, pulmonary procedures, urology and high surgical volumes. Central and Southern Illinois add community-hospital and rural-access opportunities.

Ohio has a high concentration of major health systems and specialty centers across Cleveland, Columbus, Cincinnati, Toledo and other metropolitan areas. Its provider infrastructure makes it an important market for premium reusable platforms, AI-assisted colonoscopy and advanced pulmonary endoscopy.

Michigan and Wisconsin provide substantial procedure demand through large integrated systems and aging populations. Detroit, Ann Arbor, Grand Rapids, Milwaukee and Madison contain major referral centers. Indiana and Missouri offer stable hospital and ASC demand around Indianapolis, St. Louis and Kansas City.

Minnesota is strategically important because of its medtech history, clinical expertise and integrated health systems. It can influence technology development and procurement practices beyond its population share. Iowa, Kansas and Nebraska have strong regional referral centers but also broad rural catchment areas.

North Dakota and South Dakota are smaller markets where centralized specialty care and long travel distances affect procedure access. Portable and disposable endoscopy systems can be valuable when low case volumes do not justify extensive reusable fleets or reprocessing infrastructure.

Manufacturers typically succeed in the Midwest through dependable service, strong clinical education, competitive fleet economics and long-term relationships with integrated delivery networks. Cost sensitivity is meaningful, but providers will adopt premium products when the clinical and operational benefits are well documented.

Key Market Players

The U.S. Endoscopes Market Competitive Landscape is moderately consolidated among major visualization companies, although single-use endoscopy, AI, robotic navigation and specialty endoluminal products are creating room for focused innovators.

Competition is increasingly ecosystem-based. Leading manufacturers combine endoscopes with processors, imaging algorithms, service contracts, repair programs, reprocessing compatibility, clinical education and enterprise purchasing agreements. Newer companies frequently enter through one high-growth application before expanding into adjacent specialties.

Some of the key players operating in the U.S. Endoscopes Market include:

Olympus Corporation
FUJIFILM Holdings Corporation
HOYA Corporation and PENTAX Medical
KARL STORZ SE & Co. KG
Stryker Corporation
Boston Scientific Corporation
Medtronic plc
Ambu A/S
STERIS plc
CONMED Corporation
Richard Wolf GmbH
Cook Medical
Johnson & Johnson MedTech
Intuitive Surgical, Inc.
Noah Medical Corporation
EvoEndo, Inc.
EndoQuest Robotics, Inc.
Verathon Inc.
Merit Medical Systems, Inc.
Teleflex Incorporated
Micro-Tech Endoscopy USA, Inc.
ERBE USA, Inc.
Laborie Medical Technologies
SonoScape Medical Corp.
Clarus Medical LLC

Olympus, Fujifilm, PENTAX Medical, KARL STORZ and Stryker have strong positions in reusable visualization and installed capital infrastructure. Their competitive strength is supported by broad scope portfolios, physician familiarity, service networks and compatibility with established processors.

Ambu is a major force in single-use endoscopy, particularly in bronchoscopy and expanding urology applications. Boston Scientific and Medtronic participate through GI imaging, capsule endoscopy, AI, therapeutic platforms and single-use visualization. Intuitive Surgical and Noah Medical are shaping robotic bronchoscopy and navigation-enabled pulmonary diagnosis.

Market share through 2035 will be influenced by FDA clearances, evidence quality, AI performance, product durability, service reliability, supply continuity, physician training and the ability to demonstrate lower total cost per procedure. Companies that support hybrid reusable and disposable fleets may be particularly well positioned as health systems avoid committing to a single utilization model.

Recent Developments

In March 2024, Fujifilm received U.S. FDA 510(k) clearance for CAD EYE, an AI-powered system designed to provide real-time detection of colonic mucosal lesions during colonoscopy. The clearance broadened competition in computer-aided detection and strengthened the commercial connection between AI software and endoscopy-platform purchasing.

During 2024, updated versions of the GI Genius intelligent endoscopy system and additional computer-assisted colonoscopy software received regulatory clearance. These developments indicate that the U.S. market is progressing from a small number of first-generation AI products toward a multi-platform environment with greater buyer choice.

In May 2025, Olympus announced FDA clearance for its EZ1500 series endoscopes incorporating extended depth-of-field technology. The development reflects manufacturer efforts to improve continuous image focus and visualization during gastrointestinal procedures.

In June 2025, Ambu received expanded FDA clearance for its aScope 5 Cysto HD platform, creating a single-use flexible cysto-nephroscopy solution. The clearance demonstrates how disposable endoscopy is moving beyond bronchoscopy into broader urological applications.

In July 2025, Olympus launched the EU-ME3 ultrasound processor in the United States. The system was designed to support endoscopic and endobronchial ultrasound on a common workstation, strengthening the integration of GI and pulmonary diagnostic workflows.

In September 2025, Olympus launched its OLYSENSE platform with CADDIE AI software in the United States. The platform strategy is intended to combine computer-aided detection with data connectivity and broader endoscopy-unit integration.

In 2025, Intuitive expanded the AI and advanced-imaging capabilities of its Ion endoluminal system. The software development targeted navigation challenges in robotic lung biopsy and reinforced the role of software upgrades in extending the clinical value of installed robotic platforms.

The FDA’s continued encouragement of disposable components and fully disposable alternatives for duodenoscopy remains an important structural development. The policy direction is influencing design priorities, procurement reviews and infection-control strategies across endoscopy departments.

Conclusion

The U.S. Endoscopes Market Size & Share is positioned to increase from approximately USD 5.19 billion in 2025 to USD 12.09 billion by 2035, reflecting a forecast CAGR of 8.82% from 2026 to 2035. Long-term expansion will be supported by recurring procedure demand, colorectal screening beginning at age 45, rising cancer detection, outpatient migration, replacement of aging reusable fleets and rapid innovation in AI, disposable endoscopy and robotic navigation.

Gastrointestinal endoscopy will remain the largest application because of the scale of colonoscopy, upper GI endoscopy, EUS and ERCP. Pulmonary and urology applications will contribute strong incremental growth through robotic bronchoscopy, single-use cystoscopy, ureteroscopy and advanced tissue-acquisition workflows.

Reusable flexible scopes will maintain a central role in high-volume and complex procedures, but single-use products will gain share in applications where infection control, immediate availability and predictable cost outweigh reusable-fleet economics. Most health systems are expected to operate hybrid fleets rather than replacing reusable devices entirely.

Hospitals will remain the largest end users, while ambulatory surgery centers and specialty clinics will represent some of the most attractive commercial opportunities. Buyers will increasingly demand evidence that a platform improves detection, reduces repeat procedures, increases throughput, lowers repair burden or simplifies infection-control processes.

Regionally, the South will retain the largest share because of its population scale and expanding healthcare capacity. The West will grow fastest through technology adoption and population expansion. The Northeast will remain a high-value center for advanced endoscopy and clinical evidence, while the Midwest will provide stable demand supported by mature health systems.

For manufacturers, investors, distributors and healthcare providers, the central strategic issue is not whether endoscopy utilization will continue to grow. The more important questions are which procedures will migrate to disposable platforms, how quickly AI will influence capital replacement, where robotic navigation will create clinically defensible value and how providers will balance infection prevention against cost and environmental considerations.

The companies most likely to lead the next decade will combine high-performance visualization with intelligent software, dependable service, flexible purchasing models and measurable improvements in procedure economics.

TABLE OF CONTENT

1. U.S. Endoscopes Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.2.1. Product Scope
1.2.2. Application Scope
1.2.3. End-User Scope
1.2.4. Technology Scope
1.2.5. Procurement Channel Scope
1.2.6. Geographic Scope
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Market Sizing and Forecasting Models
1.3.6. Top-Down and Bottom-Up Market Estimation
1.3.7. Data Triangulation and Validation
1.3.8. Final Report Review and Publishing
1.4. Key Market Assumptions
1.5. Historical Period, Base Year, and Forecast Period
1.6. Currency and Market Value Definition
1.7. Market Ecosystem Overview
1.8. Stakeholder Analysis
1.8.1. Endoscope Manufacturers
1.8.2. Imaging Processor and Visualization Platform Manufacturers
1.8.3. Optical, Sensor, and Electronic Component Suppliers
1.8.4. Contract Manufacturing and Sterilization Partners
1.8.5. Hospitals and Integrated Delivery Networks
1.8.6. Ambulatory Surgery Centers and Endoscopy Centers
1.8.7. Gastroenterology, Pulmonology, Urology, ENT, and Surgical Practices
1.8.8. Group Purchasing Organizations
1.8.9. Medical Device Distributors and Specialty Suppliers
1.8.10. Reprocessing and Infection-Prevention Service Providers
1.8.11. Payers, Regulators, and Clinical Decision-Makers

What this section provides: This section defines the U.S. endoscopes market boundary, study methodology, product inclusions, forecasting assumptions, stakeholder structure, and validation process so clients understand how market values and opportunities are measured.

2. U.S. Endoscopes Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size and CAGR Summary
2.8. Leading Product Segment
2.9. Fastest-Growing Product Segment
2.10. Leading Application Segment
2.11. Fastest-Growing Application Segment
2.12. Leading End-User Segment
2.13. Leading Technology Segment
2.14. Regional Leadership and Growth Hotspots
2.15. High-Growth Opportunity Areas
2.16. Key Strategic Findings for Market Participants

What this section provides: This section gives decision-makers a concise view of market size, historical performance, forecast growth, segment leadership, technology shifts, regional opportunities, and the most commercially important endoscopy market developments.

3. U.S. Endoscopes Market: Market Dynamics & Outlook

3.1. Market Drivers and Their Impact Analysis
3.1.1. Large U.S. Colonoscopy and Gastrointestinal Procedure Base
3.1.2. Expansion of Colorectal Cancer Screening Among Adults Aged 45 and Above
3.1.3. Rising Burden of Gastrointestinal, Pulmonary, Urological, and Gynecological Diseases
3.1.4. Increasing Adoption of Minimally Invasive Diagnostic and Surgical Procedures
3.1.5. Expansion of Ambulatory Surgery Centers and Dedicated Endoscopy Centers
3.1.6. Replacement of Aging Reusable Endoscope Fleets
3.1.7. Growing Adoption of Single-Use Endoscopes
3.1.8. Rising Demand for AI-Assisted Lesion Detection
3.1.9. Growth of Robotic Bronchoscopy and Navigation-Assisted Procedures
3.1.10. Increasing Use of Endoscopic Ultrasound and Advanced Therapeutic Endoscopy
3.2. Market Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Premium Endoscopy Platforms
3.2.2. Reusable Endoscope Repair and Maintenance Costs
3.2.3. Complex Cleaning, Disinfection, Drying, and Storage Requirements
3.2.4. Reimbursement Pressure and Value Analysis Committee Scrutiny
3.2.5. Limited Specialist Availability in Rural and Underserved Areas
3.2.6. Environmental Concerns Associated with Single-Use Devices
3.2.7. Vendor Lock-In and Processor Compatibility Constraints
3.2.8. Product Recall, Infection, and Patient-Safety Risks
3.3. Market Opportunities and Their Impact Analysis
3.3.1. Single-Use Bronchoscopy, Urology, and ENT Platforms
3.3.2. AI-Assisted Colonoscopy and Endoscopy Quality Analytics
3.3.3. Robotic and Navigation-Assisted Peripheral Lung Biopsy
3.3.4. Expansion of Endoscopic Ultrasound Applications
3.3.5. Office-Based and Unsedated Endoscopy
3.3.6. Capsule Endoscopy and AI-Assisted Image Interpretation
3.3.7. Rural and Community Hospital Endoscopy Access
3.3.8. Hybrid Reusable and Single-Use Fleet Models
3.3.9. Enterprise Endoscopy Asset-Management Platforms
3.3.10. Advanced Endoluminal and Third-Space Procedures
3.4. Market Challenges and Their Impact Analysis
3.4.1. Balancing Clinical Performance and Cost per Procedure
3.4.2. Managing Reprocessing Compliance Across Multiple Sites
3.4.3. Physician Training Requirements for Advanced Platforms
3.4.4. Supply-Chain Reliability for Single-Use Endoscopes
3.4.5. Integration of AI with Legacy Endoscopy Systems
3.5. Patent & Innovation Analysis, 2021–2025
3.6. Clinical Workflow Economics Analysis
3.6.1. Procedure-Room Turnover Economics
3.6.2. Reusable Endoscope Cost per Procedure
3.6.3. Single-Use Endoscope Cost per Procedure
3.6.4. Repair, Reprocessing, and Downtime Economics
3.6.5. Repeat Procedure and Missed-Lesion Economics
3.7. Hospital Capital Procurement Behavior Analysis
3.7.1. Capital Budget Approval Process
3.7.2. Endoscopy Platform Standardization
3.7.3. Fleet Replacement Cycles
3.7.4. Service Contract and Loaner Scope Requirements
3.7.5. Physician Preference and Value Analysis Committee Influence

What this section provides: This section explains the clinical, procedural, financial, infection-control, reimbursement, and operational forces shaping endoscope demand, enabling clients to assess growth drivers, adoption barriers, and execution risks.

4. U.S. Endoscopes Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political Factors
4.1.2. Economic Factors
4.1.3. Social Factors
4.1.4. Technological Factors
4.1.5. Environmental Factors
4.1.6. Legal Factors
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitution
4.2.5. Competitive Rivalry
4.3. Pricing Trend Analysis, 2021–2035
4.3.1. Reusable Flexible Endoscope Pricing
4.3.2. Rigid Endoscope Pricing
4.3.3. Single-Use Endoscope Pricing
4.3.4. Capsule Endoscope Pricing
4.3.5. Robotic and Navigation Platform Pricing
4.4. Value Chain Analysis
4.5. Supply Chain Analysis
4.5.1. Optical Components and Image Sensors
4.5.2. Electronic Components and Processors
4.5.3. Endoscope Assembly and Testing
4.5.4. Sterilization and Packaging
4.5.5. Distribution and Installation
4.5.6. Repair, Maintenance, and Reprocessing Support
4.6. Application & Innovation Landscape
4.7. Impact of Digitalization and Connected Endoscopy
4.8. Artificial Intelligence Adoption Landscape
4.9. FDA Regulatory Framework Analysis
4.9.1. FDA 510(k) Clearance Pathway
4.9.2. De Novo Classification Pathway
4.9.3. Premarket Approval Considerations
4.9.4. Medical Device Reporting Requirements
4.9.5. Reusable Device Reprocessing Requirements
4.9.6. Single-Use Device Regulatory Considerations
4.10. CMS Reimbursement and Coverage Landscape
4.10.1. Hospital Outpatient Reimbursement
4.10.2. Ambulatory Surgery Center Reimbursement
4.10.3. Physician Fee Schedule Considerations
4.10.4. Screening and Diagnostic Colonoscopy Coverage
4.10.5. Bronchoscopy and Pulmonary Procedure Reimbursement
4.10.6. Urology and ENT Procedure Reimbursement
4.11. Infection Prevention and Endoscope Reprocessing Landscape
4.11.1. High-Level Disinfection Requirements
4.11.2. Sterilization Requirements
4.11.3. Endoscope Drying and Storage
4.11.4. Reprocessing Documentation and Traceability
4.11.5. Disposable Component and Single-Use Adoption
4.12. Import, Export, and Tariff Impact
4.13. Government Initiatives and Cancer-Screening Programs
4.14. Impact of Escalating Geopolitical Tensions
4.15. Environmental Sustainability and Medical Waste Analysis
4.16. Hospital Value Analysis Committee Decision Framework
4.16.1. Clinical Performance
4.16.2. Procedure Throughput
4.16.3. Infection-Control Risk
4.16.4. Capital and Operating Cost
4.16.5. Repair and Service Support
4.16.6. Physician Training and Adoption
4.16.7. Platform Compatibility and Cybersecurity

What this section provides: This section gives clients a complete view of the regulatory, reimbursement, pricing, supply-chain, infection-control, sustainability, technology, and procurement environment affecting the U.S. endoscopes industry.

5. U.S. Endoscopes Market – By Product Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Flexible Endoscopes
5.1.2.1. Colonoscopes
5.1.2.2. Gastroscopes
5.1.2.3. Duodenoscopes
5.1.2.4. Enteroscopes
5.1.2.5. Bronchoscopes
5.1.2.6. Cystoscopes
5.1.2.7. Ureteroscopes
5.1.2.8. Choledochoscopes
5.1.2.9. Rhinoscopes and Laryngoscopes
5.1.2.10. Other Flexible Endoscopes
5.1.3. Rigid Endoscopes
5.1.3.1. Laparoscopes
5.1.3.2. Arthroscopes
5.1.3.3. Hysteroscopes
5.1.3.4. Rigid Cystoscopes
5.1.3.5. Sinuscopes
5.1.3.6. Neuroendoscopes
5.1.3.7. Other Rigid Endoscopes
5.1.4. Single-Use Endoscopes
5.1.4.1. Single-Use Bronchoscopes
5.1.4.2. Single-Use Cystoscopes
5.1.4.3. Single-Use Ureteroscopes
5.1.4.4. Single-Use Nephroscopes
5.1.4.5. Single-Use Gastroscopes
5.1.4.6. Single-Use ENT Endoscopes
5.1.4.7. Other Single-Use Endoscopes
5.1.5. Capsule Endoscopes
5.1.5.1. Small-Bowel Capsule Endoscopes
5.1.5.2. Colon Capsule Endoscopes
5.1.5.3. Esophageal Capsule Endoscopes
5.1.6. Robot-Assisted and Navigation-Enabled Endoscopes
5.1.6.1. Robotic Bronchoscopy Systems
5.1.6.2. Navigation-Assisted Bronchoscopy Systems
5.1.6.3. Robotic Endoluminal Systems
5.1.6.4. Other Navigation-Enabled Endoscopes

What this section provides: This section identifies the endoscope product categories expected to generate the highest revenue, strongest procedure demand, fastest replacement cycles, and most attractive growth through 2035.

6. U.S. Endoscopes Market – By Application

6.1. Overview
6.1.1. Segment Share Analysis, By Application, 2025 & 2035 (%)
6.1.2. Gastrointestinal Endoscopy
6.1.2.1. Colonoscopy
6.1.2.2. Upper Gastrointestinal Endoscopy
6.1.2.3. Endoscopic Retrograde Cholangiopancreatography
6.1.2.4. Endoscopic Ultrasound
6.1.2.5. Enteroscopy
6.1.2.6. Capsule Endoscopy
6.1.2.7. Advanced Therapeutic and Third-Space Endoscopy
6.1.3. Laparoscopy and General Surgery
6.1.3.1. General Abdominal Surgery
6.1.3.2. Bariatric Surgery
6.1.3.3. Colorectal Surgery
6.1.3.4. Hepatobiliary Surgery
6.1.4. Urology Endoscopy
6.1.4.1. Cystoscopy
6.1.4.2. Ureteroscopy
6.1.4.3. Nephroscopy
6.1.4.4. Bladder Cancer Surveillance
6.1.4.5. Kidney Stone Management
6.1.5. Bronchoscopy and Pulmonary Endoscopy
6.1.5.1. Diagnostic Bronchoscopy
6.1.5.2. Therapeutic Bronchoscopy
6.1.5.3. Endobronchial Ultrasound
6.1.5.4. Robotic and Navigation-Assisted Lung Biopsy
6.1.5.5. Intensive Care and Emergency Bronchoscopy
6.1.6. Ear, Nose, and Throat Endoscopy
6.1.6.1. Rhinoscopy
6.1.6.2. Laryngoscopy
6.1.6.3. Endoscopic Sinus Surgery
6.1.7. Gynecology Endoscopy
6.1.7.1. Diagnostic Hysteroscopy
6.1.7.2. Operative Hysteroscopy
6.1.7.3. Gynecological Laparoscopy
6.1.8. Orthopedic Endoscopy
6.1.8.1. Knee Arthroscopy
6.1.8.2. Shoulder Arthroscopy
6.1.8.3. Hip Arthroscopy
6.1.8.4. Small-Joint Arthroscopy
6.1.9. Neuroendoscopy
6.1.9.1. Cranial Neuroendoscopy
6.1.9.2. Spinal Endoscopy
6.1.10. Other Endoscopic Applications

What this section provides: This section helps clients understand demand by clinical procedure, disease pathway, and specialty, allowing them to prioritize applications with strong utilization, reimbursement relevance, and technology adoption.

7. U.S. Endoscopes Market – By End User

7.1. Overview
7.1.1. Segment Share Analysis, By End User, 2025 & 2035 (%)
7.1.2. Hospitals and Integrated Health Systems
7.1.2.1. Academic Hospitals
7.1.2.2. Community Hospitals
7.1.2.3. Specialty Hospitals
7.1.2.4. Government and Veterans Health Facilities
7.1.3. Ambulatory Surgery Centers and Dedicated Endoscopy Centers
7.1.3.1. Gastroenterology Endoscopy Centers
7.1.3.2. Multispecialty Ambulatory Surgery Centers
7.1.3.3. Physician-Owned Surgery Centers
7.1.4. Specialty Clinics and Physician Offices
7.1.4.1. Gastroenterology Practices
7.1.4.2. Pulmonology Practices
7.1.4.3. Urology Practices
7.1.4.4. ENT Practices
7.1.4.5. Gynecology Practices
7.1.5. Academic Medical Centers and Specialty Referral Institutions
7.1.6. Rural Hospitals and Community Healthcare Facilities
7.1.7. Mobile Endoscopy and Outreach Services

What this section provides: This section explains which healthcare settings and customer groups drive endoscope purchasing, utilization, fleet replacement, recurring procedure demand, and adoption of advanced or single-use technologies.

8. U.S. Endoscopes Market – By Technology Type

8.1. Overview
8.1.1. Segment Share Analysis, By Technology Type, 2025 & 2035 (%)
8.1.2. High-Definition and 4K Imaging Endoscopes
8.1.2.1. High-Definition Imaging
8.1.2.2. 4K Ultra-High-Definition Imaging
8.1.2.3. Extended Depth-of-Field Imaging
8.1.2.4. Optical and Digital Contrast Enhancement
8.1.3. AI-Compatible and Computer-Assisted Endoscopy
8.1.3.1. Computer-Aided Detection
8.1.3.2. Computer-Aided Diagnosis
8.1.3.3. Automated Quality Measurement
8.1.3.4. Procedure Documentation and Analytics
8.1.4. Endoscopic Ultrasound-Enabled Systems
8.1.4.1. Gastrointestinal Endoscopic Ultrasound
8.1.4.2. Endobronchial Ultrasound
8.1.5. Single-Use Digital Imaging Technology
8.1.5.1. CMOS-Based Single-Use Imaging
8.1.5.2. Portable Monitor-Based Platforms
8.1.5.3. Integrated Single-Use Visualization Systems
8.1.6. Robotic and Navigation-Assisted Technology
8.1.6.1. Robotic Bronchoscopy
8.1.6.2. Electromagnetic Navigation
8.1.6.3. Shape-Sensing Navigation
8.1.6.4. Robotic Endoluminal Navigation
8.1.7. Capsule Imaging and AI-Assisted Capsule Review

What this section provides: This section evaluates the imaging, AI, ultrasound, disposable, robotic, navigation, and capsule technologies shaping clinical performance, endoscope differentiation, and future purchasing decisions.

9. U.S. Endoscopes Market – By Procurement Channel

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Channel, 2025 & 2035 (%)
9.1.2. Direct Hospital and Health System Procurement
9.1.2.1. Capital Equipment Purchases
9.1.2.2. Fleet Replacement Contracts
9.1.2.3. Service and Repair Agreements
9.1.2.4. Lease and Managed Equipment Models
9.1.3. Integrated Delivery Network Enterprise Contracts
9.1.3.1. Multi-Hospital Standardization
9.1.3.2. Enterprise Pricing Agreements
9.1.3.3. Platform and Processor Standardization
9.1.4. Group Purchasing Organization Contracts
9.1.4.1. National GPO Contracts
9.1.4.2. Regional Purchasing Collaboratives
9.1.5. Distributor and Specialty Supplier Sales
9.1.5.1. Full-Line Medical Device Distributors
9.1.5.2. Specialty Endoscopy Distributors
9.1.5.3. Independent Sales Channels
9.1.6. Ambulatory and Office-Based Procurement
9.1.6.1. Ambulatory Surgery Center Procurement
9.1.6.2. Dedicated Endoscopy Center Procurement
9.1.6.3. Specialty Clinic and Physician-Office Procurement
9.1.7. Digital and Direct-to-Facility Ordering for Single-Use Endoscopes

What this section provides: This section helps clients understand how endoscopes are purchased in the United States, including hospital contracting, IDN standardization, GPO influence, distributor participation, service agreements, and ambulatory procurement behavior.

10. U.S. Endoscopes Market – By Geography
10.1. Introduction

10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional Endoscopic Procedure Volume Analysis
10.1.4. Regional Hospital and Ambulatory Infrastructure Analysis
10.1.5. Regional Gastroenterologist, Pulmonologist, Urologist, and Surgeon Availability
10.1.6. Regional Cancer-Screening and Disease-Burden Analysis
10.1.7. Regional Reimbursement and Payer-Mix Analysis
10.1.8. Regional Procurement and Endoscope Replacement Dynamics

10.2. West Region

10.2.1. Regional Overview & Trends
10.2.2. West Region Endoscope Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3. Northeast Region

10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Endoscope Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4. South Region

10.4.1. Regional Overview & Trends
10.4.2. South Region Endoscope Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5. Midwest Region

10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Endoscope Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Application, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By End User, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Technology Type, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Channel, 2021–2035 (US$ Billion)

What this section provides: This section delivers detailed regional and state-level analysis, helping clients identify endoscopy procedure hubs, hospital and ASC clusters, AI-adoption hotspots, single-use scope opportunities, and state-level commercial priorities across all 50 U.S. states.

11. U.S. Endoscopes Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking
11.2.1. Product Portfolio Breadth
11.2.2. Installed Platform Base
11.2.3. Single-Use Endoscope Positioning
11.2.4. AI and Software Capabilities
11.2.5. Robotic and Navigation Capabilities
11.2.6. Service and Repair Network
11.2.7. U.S. Hospital and ASC Market Access
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Emerging Players
11.4. Company Profiles
11.4.1. Olympus Corporation
11.4.2. FUJIFILM Holdings Corporation
11.4.3. HOYA Corporation – PENTAX Medical
11.4.4. KARL STORZ SE & Co. KG
11.4.5. Stryker Corporation
11.4.6. Boston Scientific Corporation
11.4.7. Medtronic plc
11.4.8. Ambu A/S
11.4.9. STERIS plc
11.4.10. CONMED Corporation
11.4.11. Richard Wolf GmbH
11.4.12. Cook Medical
11.4.13. Johnson & Johnson MedTech
11.4.14. Intuitive Surgical, Inc.
11.4.15. Noah Medical Corporation
11.4.16. EvoEndo, Inc.
11.4.17. EndoQuest Robotics, Inc.
11.4.18. Verathon Inc.
11.4.19. Merit Medical Systems, Inc.
11.4.20. Teleflex Incorporated
11.4.21. Micro-Tech Endoscopy USA, Inc.
11.4.22. ERBE USA, Inc.
11.4.23. Laborie Medical Technologies
11.4.24. SonoScape Medical Corp.
11.4.25. Clarus Medical LLC

Note: Each company profile will include company overview, endoscope and visualization portfolio, U.S. market strategy, financial positioning, regulatory clearances, AI and software capabilities, clinical partnerships, product launches, acquisitions, service infrastructure, and recent developments.

What this section provides: This section gives clients market-share visibility, competitor benchmarking, portfolio positioning, innovation direction, commercial strategy, and detailed intelligence on leading and emerging U.S. endoscope suppliers.

12. U.S. Endoscopes Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technology Impact
12.2.1. AI-Assisted Polyp and Lesion Detection
12.2.2. AI-Based Lesion Characterization
12.2.3. Single-Use Endoscope Expansion
12.2.4. Robotic Bronchoscopy and Peripheral Lung Navigation
12.2.5. Capsule Endoscopy and Automated Image Review
12.2.6. Endoscopic Ultrasound Integration
12.2.7. Robotic Endoluminal Surgery
12.2.8. Extended Depth-of-Field and Advanced Optical Imaging
12.2.9. Connected Endoscopy and Automated Quality Reporting
12.3. Emerging Business Trends
12.3.1. Hybrid Reusable and Disposable Fleets
12.3.2. Managed Equipment and Subscription Models
12.3.3. Enterprise Endoscopy Standardization
12.3.4. ASC-Focused Product Development
12.3.5. Sustainability and Circular-Economy Initiatives
12.3.6. Software-Led Product Differentiation
12.4. Business Opportunities for Startups and Existing Players
12.5. Investment Prioritization Matrix
12.6. Product White-Space Analysis
12.7. Procedure-Specific Growth Opportunity Analysis
12.8. Regional Opportunity Prioritization, 2026–2035

What this section provides: This section prepares clients for future technology transitions, changing endoscope fleet models, evolving procedure economics, investment opportunities, and potential market-development scenarios through 2035.

13. U.S. Endoscopes Market: Strategic Recommendations

13.1. Recommendations for Endoscope Manufacturers
13.2. Recommendations for Hospitals and Integrated Health Systems
13.3. Recommendations for Ambulatory Surgery Centers and Endoscopy Centers
13.4. Recommendations for Gastroenterology, Pulmonology, Urology, ENT, and Surgical Practices
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for New Entrants and Startups
13.8. Go-to-Market Strategy Considerations
13.8.1. Hospital Market Entry Strategy
13.8.2. ASC Market Entry Strategy
13.8.3. Specialty Clinic Market Entry Strategy
13.8.4. Regional Distribution Strategy
13.9. Product Positioning and Portfolio Expansion Guidance
13.9.1. Reusable Endoscope Portfolio Strategy
13.9.2. Single-Use Endoscope Portfolio Strategy
13.9.3. AI and Software Strategy
13.9.4. Robotic and Navigation Platform Strategy
13.9.5. Service, Repair, and Managed Equipment Strategy
13.10. Pricing and Contracting Recommendations
13.11. Clinical Evidence and Regulatory Strategy
13.12. Partnership, Acquisition, and Licensing Opportunities

What this section provides: This section converts market intelligence into actionable recommendations for market entry, product positioning, portfolio expansion, hospital contracting, ASC penetration, investment planning, and competitive differentiation.

14. U.S. Endoscopes Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Definition Limitation
14.4. Forecasting Limitation
14.5. Legal Disclaimer
14.6. Third-Party Data Disclaimer
14.7. Company and Product Information Disclaimer
14.8. Regulatory and Reimbursement Disclaimer

What this section provides: This section clarifies the report’s scope limitations, forecasting assumptions, legal boundaries, data-use conditions, and restrictions relating to company, product, regulatory, and reimbursement information.

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Endoscopes Market: Market Definition and Scope
TABLE 3: U.S. Endoscopes Market: Research Methodology Framework
TABLE 4: U.S. Endoscopes Market: Key Assumptions
TABLE 5: U.S. Endoscopes Market: Market Ecosystem Overview
TABLE 6: U.S. Endoscopes Market: Stakeholder Analysis
TABLE 7: U.S. Endoscopes Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Endoscopes Market: Analyst Viewpoint Summary
TABLE 9: U.S. Endoscopes Market: Market Attractiveness Index
TABLE 10: U.S. Endoscopes Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Endoscopes Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Endoscopes Market: Year-wise Market Size, 2021–2035 (US$ Billion)
TABLE 13: U.S. Endoscopes Market: Drivers; Impact Analysis
TABLE 14: U.S. Endoscopes Market: Restraints; Impact Analysis
TABLE 15: U.S. Endoscopes Market: Opportunities; Impact Analysis
TABLE 16: U.S. Endoscopes Market: Challenges; Impact Analysis
TABLE 17: U.S. Endoscopes Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Endoscopes Market: Clinical Workflow Economics Matrix
TABLE 19: U.S. Endoscopes Market: Hospital Capital Procurement Behavior Matrix
TABLE 20: U.S. Endoscopes Market: PESTEL Analysis
TABLE 21: U.S. Endoscopes Market: Porter’s Five Forces Analysis
TABLE 22: U.S. Endoscopes Market: Pricing Trend Analysis, 2021–2035
TABLE 23: U.S. Endoscopes Market: Value Chain Analysis
TABLE 24: U.S. Endoscopes Market: Supply Chain Analysis
TABLE 25: U.S. Endoscopes Market: Application & Innovation Landscape
TABLE 26: U.S. Endoscopes Market: Digitalization and Connected Endoscopy Impact
TABLE 27: U.S. Endoscopes Market: Artificial Intelligence Adoption Landscape
TABLE 28: U.S. Endoscopes Market: FDA Regulatory Framework Analysis
TABLE 29: U.S. Endoscopes Market: CMS Reimbursement and Coverage Landscape
TABLE 30: U.S. Endoscopes Market: Infection Prevention and Endoscope Reprocessing Landscape
TABLE 31: U.S. Endoscopes Market: Import, Export and Tariff Impact
TABLE 32: U.S. Endoscopes Market: Government Initiatives and Cancer-Screening Programs
TABLE 33: U.S. Endoscopes Market: Impact of Escalating Geopolitical Tensions
TABLE 34: U.S. Endoscopes Market: Environmental Sustainability and Medical Waste Analysis
TABLE 35: U.S. Endoscopes Market: Hospital Value Analysis Committee Decision Framework
TABLE 36: U.S. Endoscopes Market: Product Type Snapshot, 2025
TABLE 37: Segment Dashboard; Definition and Scope, by Product Type
TABLE 38: U.S. Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 39: U.S. Endoscopes Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 40: U.S. Endoscopes Market: Flexible Endoscopes Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 41: U.S. Endoscopes Market: Rigid Endoscopes Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: U.S. Endoscopes Market: Single-Use Endoscopes Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: U.S. Endoscopes Market: Capsule Endoscopes Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: U.S. Endoscopes Market: Robot-Assisted and Navigation-Enabled Endoscopes Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: U.S. Endoscopes Market: Application Snapshot, 2025
TABLE 46: Segment Dashboard; Definition and Scope, by Application
TABLE 47: U.S. Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 48: U.S. Endoscopes Market: Segment Share Analysis, by Application, 2025 & 2035 (%)
TABLE 49: U.S. Endoscopes Market: Gastrointestinal Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 50: U.S. Endoscopes Market: Laparoscopy and General Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: U.S. Endoscopes Market: Urology Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: U.S. Endoscopes Market: Bronchoscopy and Pulmonary Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: U.S. Endoscopes Market: Ear, Nose and Throat Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: U.S. Endoscopes Market: Gynecology Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Endoscopes Market: Orthopedic Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 56: U.S. Endoscopes Market: Neuroendoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 57: U.S. Endoscopes Market: Other Endoscopic Applications Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 58: U.S. Endoscopes Market: End User Snapshot, 2025
TABLE 59: Segment Dashboard; Definition and Scope, by End User
TABLE 60: U.S. Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 61: U.S. Endoscopes Market: Segment Share Analysis, by End User, 2025 & 2035 (%)
TABLE 62: U.S. Endoscopes Market: Hospitals and Integrated Health Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: U.S. Endoscopes Market: Ambulatory Surgery Centers and Dedicated Endoscopy Centers Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: U.S. Endoscopes Market: Specialty Clinics and Physician Offices Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: U.S. Endoscopes Market: Academic Medical Centers and Specialty Referral Institutions Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: U.S. Endoscopes Market: Rural Hospitals and Community Healthcare Facilities Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Endoscopes Market: Mobile Endoscopy and Outreach Services Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 68: U.S. Endoscopes Market: Technology Type Snapshot, 2025
TABLE 69: Segment Dashboard; Definition and Scope, by Technology Type
TABLE 70: U.S. Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 71: U.S. Endoscopes Market: Segment Share Analysis, by Technology Type, 2025 & 2035 (%)
TABLE 72: U.S. Endoscopes Market: High-Definition and 4K Imaging Endoscopes Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: U.S. Endoscopes Market: AI-Compatible and Computer-Assisted Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: U.S. Endoscopes Market: Endoscopic Ultrasound-Enabled Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Endoscopes Market: Single-Use Digital Imaging Technology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 76: U.S. Endoscopes Market: Robotic and Navigation-Assisted Technology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 77: U.S. Endoscopes Market: Capsule Imaging and AI-Assisted Capsule Review Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 78: U.S. Endoscopes Market: Procurement Channel Snapshot, 2025
TABLE 79: Segment Dashboard; Definition and Scope, by Procurement Channel
TABLE 80: U.S. Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 81: U.S. Endoscopes Market: Segment Share Analysis, by Procurement Channel, 2025 & 2035 (%)
TABLE 82: U.S. Endoscopes Market: Direct Hospital and Health System Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Endoscopes Market: Integrated Delivery Network Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 84: U.S. Endoscopes Market: Group Purchasing Organization Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 85: U.S. Endoscopes Market: Distributor and Specialty Supplier Sales Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 86: U.S. Endoscopes Market: Ambulatory and Office-Based Procurement Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 87: U.S. Endoscopes Market: Digital and Direct-to-Facility Ordering for Single-Use Endoscopes Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 88: U.S. Endoscopes Market: Regional Snapshot, 2025
TABLE 89: Segment Dashboard; Definition and Scope, by Region
TABLE 90: U.S. Endoscopes Market, by Region, 2021–2035 (US$ Billion)
TABLE 91: U.S. Endoscopes Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 92: West Region U.S. Endoscopes Market: Regional Overview and Trends
TABLE 93: West Region U.S. Endoscopes Market: Key Manufacturers and Procurement Ecosystem
TABLE 94: West Region U.S. Endoscopes Market, by State, 2021–2035 (US$ Billion)
TABLE 95: West Region U.S. Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 96: West Region U.S. Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 97: West Region U.S. Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 98: West Region U.S. Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 99: West Region U.S. Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 100: California Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 101: California Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 102: California Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 103: California Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 104: California Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 105: Washington Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 106: Washington Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 107: Washington Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 108: Washington Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 109: Washington Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 110: Arizona Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 111: Arizona Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 112: Arizona Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 113: Arizona Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 114: Arizona Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 115: Colorado Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 116: Colorado Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 117: Colorado Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 118: Colorado Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 119: Colorado Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 120: Oregon Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 121: Oregon Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 122: Oregon Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 123: Oregon Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 124: Oregon Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 125: Utah Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 126: Utah Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 127: Utah Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 128: Utah Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 129: Utah Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 130: Nevada Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 131: Nevada Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 132: Nevada Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 133: Nevada Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 134: Nevada Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 135: New Mexico Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 136: New Mexico Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 137: New Mexico Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 138: New Mexico Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 139: New Mexico Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 140: Idaho Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 141: Idaho Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 142: Idaho Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 143: Idaho Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 144: Idaho Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 145: Montana Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 146: Montana Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 147: Montana Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 148: Montana Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 149: Montana Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 150: Wyoming Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 151: Wyoming Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 152: Wyoming Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 153: Wyoming Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 154: Wyoming Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 155: Alaska Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 156: Alaska Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 157: Alaska Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 158: Alaska Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 159: Alaska Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 160: Hawaii Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 161: Hawaii Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 162: Hawaii Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 163: Hawaii Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 164: Hawaii Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 165: Northeast Region U.S. Endoscopes Market: Regional Overview and Trends
TABLE 166: Northeast Region U.S. Endoscopes Market: Key Manufacturers and Procurement Ecosystem
TABLE 167: Northeast Region U.S. Endoscopes Market, by State, 2021–2035 (US$ Billion)
TABLE 168: Northeast Region U.S. Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 169: Northeast Region U.S. Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 170: Northeast Region U.S. Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 171: Northeast Region U.S. Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 172: Northeast Region U.S. Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 173: New York Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 174: New York Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 175: New York Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 176: New York Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 177: New York Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 178: Massachusetts Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 179: Massachusetts Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 180: Massachusetts Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 181: Massachusetts Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 182: Massachusetts Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 183: New Jersey Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 184: New Jersey Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 185: New Jersey Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 186: New Jersey Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 187: New Jersey Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 188: Pennsylvania Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 189: Pennsylvania Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 190: Pennsylvania Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 191: Pennsylvania Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 192: Pennsylvania Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 193: Connecticut Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 194: Connecticut Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 195: Connecticut Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 196: Connecticut Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 197: Connecticut Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 198: Maine Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 199: Maine Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 200: Maine Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 201: Maine Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 202: Maine Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 203: Vermont Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 204: Vermont Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 205: Vermont Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 206: Vermont Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 207: Vermont Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 208: New Hampshire Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 209: New Hampshire Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 210: New Hampshire Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 211: New Hampshire Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 212: New Hampshire Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 213: Rhode Island Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 214: Rhode Island Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 215: Rhode Island Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 216: Rhode Island Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 217: Rhode Island Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 218: Delaware Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 219: Delaware Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 220: Delaware Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 221: Delaware Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 222: Delaware Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 223: South Region U.S. Endoscopes Market: Regional Overview and Trends
TABLE 224: South Region U.S. Endoscopes Market: Key Manufacturers and Procurement Ecosystem
TABLE 225: South Region U.S. Endoscopes Market, by State, 2021–2035 (US$ Billion)
TABLE 226: South Region U.S. Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 227: South Region U.S. Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 228: South Region U.S. Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 229: South Region U.S. Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 230: South Region U.S. Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 231: Texas Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 232: Texas Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 233: Texas Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 234: Texas Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 235: Texas Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 236: Florida Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 237: Florida Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 238: Florida Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 239: Florida Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 240: Florida Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 241: Georgia Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 242: Georgia Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 243: Georgia Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 244: Georgia Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 245: Georgia Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 246: North Carolina Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 247: North Carolina Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 248: North Carolina Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 249: North Carolina Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 250: North Carolina Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 251: Tennessee Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 252: Tennessee Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 253: Tennessee Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 254: Tennessee Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 255: Tennessee Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 256: South Carolina Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 257: South Carolina Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 258: South Carolina Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 259: South Carolina Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 260: South Carolina Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 261: Alabama Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 262: Alabama Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 263: Alabama Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 264: Alabama Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 265: Alabama Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 266: Mississippi Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 267: Mississippi Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 268: Mississippi Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 269: Mississippi Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 270: Mississippi Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 271: Louisiana Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 272: Louisiana Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 273: Louisiana Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 274: Louisiana Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 275: Louisiana Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 276: Arkansas Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 277: Arkansas Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 278: Arkansas Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 279: Arkansas Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 280: Arkansas Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 281: Kentucky Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 282: Kentucky Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 283: Kentucky Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 284: Kentucky Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 285: Kentucky Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 286: Oklahoma Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 287: Oklahoma Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 288: Oklahoma Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 289: Oklahoma Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 290: Oklahoma Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 291: Virginia Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 292: Virginia Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 293: Virginia Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 294: Virginia Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 295: Virginia Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 296: Maryland Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 297: Maryland Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 298: Maryland Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 299: Maryland Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 300: Maryland Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 301: West Virginia Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 302: West Virginia Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 303: West Virginia Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 304: West Virginia Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 305: West Virginia Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 306: Midwest Region U.S. Endoscopes Market: Regional Overview and Trends
TABLE 307: Midwest Region U.S. Endoscopes Market: Key Manufacturers and Procurement Ecosystem
TABLE 308: Midwest Region U.S. Endoscopes Market, by State, 2021–2035 (US$ Billion)
TABLE 309: Midwest Region U.S. Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 310: Midwest Region U.S. Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 311: Midwest Region U.S. Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 312: Midwest Region U.S. Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 313: Midwest Region U.S. Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 314: Illinois Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 315: Illinois Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 316: Illinois Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 317: Illinois Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 318: Illinois Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 319: Ohio Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 320: Ohio Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 321: Ohio Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 322: Ohio Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 323: Ohio Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 324: Michigan Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 325: Michigan Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 326: Michigan Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 327: Michigan Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 328: Michigan Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 329: Minnesota Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 330: Minnesota Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 331: Minnesota Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 332: Minnesota Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 333: Minnesota Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 334: Indiana Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 335: Indiana Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 336: Indiana Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 337: Indiana Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 338: Indiana Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 339: Wisconsin Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 340: Wisconsin Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 341: Wisconsin Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 342: Wisconsin Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 343: Wisconsin Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 344: Missouri Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 345: Missouri Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 346: Missouri Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 347: Missouri Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 348: Missouri Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 349: Iowa Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 350: Iowa Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 351: Iowa Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 352: Iowa Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 353: Iowa Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 354: Kansas Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 355: Kansas Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 356: Kansas Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 357: Kansas Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 358: Kansas Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 359: Nebraska Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 360: Nebraska Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 361: Nebraska Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 362: Nebraska Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 363: Nebraska Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 364: North Dakota Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 365: North Dakota Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 366: North Dakota Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 367: North Dakota Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 368: North Dakota Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 369: South Dakota Endoscopes Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 370: South Dakota Endoscopes Market, by Application, 2021–2035 (US$ Billion)
TABLE 371: South Dakota Endoscopes Market, by End User, 2021–2035 (US$ Billion)
TABLE 372: South Dakota Endoscopes Market, by Technology Type, 2021–2035 (US$ Billion)
TABLE 373: South Dakota Endoscopes Market, by Procurement Channel, 2021–2035 (US$ Billion)
TABLE 374: U.S. Endoscopes Market: Competitive Landscape Snapshot, 2025
TABLE 375: U.S. Endoscopes Market: Key Company Market Share Analysis, 2025
TABLE 376: U.S. Endoscopes Market: Company Positioning Matrix
TABLE 377: U.S. Endoscopes Market: Product Portfolio Benchmarking of Key Players
TABLE 378: U.S. Endoscopes Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 379: Olympus Corporation: Company Profile
TABLE 380: FUJIFILM Holdings Corporation: Company Profile
TABLE 381: HOYA Corporation – PENTAX Medical: Company Profile
TABLE 382: KARL STORZ SE & Co. KG: Company Profile
TABLE 383: Stryker Corporation: Company Profile
TABLE 384: Boston Scientific Corporation: Company Profile
TABLE 385: Medtronic plc: Company Profile
TABLE 386: Ambu A/S: Company Profile
TABLE 387: STERIS plc: Company Profile
TABLE 388: CONMED Corporation: Company Profile
TABLE 389: Richard Wolf GmbH: Company Profile
TABLE 390: Cook Medical: Company Profile
TABLE 391: Johnson & Johnson MedTech: Company Profile
TABLE 392: Intuitive Surgical, Inc.: Company Profile
TABLE 393: Noah Medical Corporation: Company Profile
TABLE 394: EvoEndo, Inc.: Company Profile
TABLE 395: EndoQuest Robotics, Inc.: Company Profile
TABLE 396: Verathon Inc.: Company Profile
TABLE 397: Merit Medical Systems, Inc.: Company Profile
TABLE 398: Teleflex Incorporated: Company Profile
TABLE 399: Micro-Tech Endoscopy USA, Inc.: Company Profile
TABLE 400: ERBE USA, Inc.: Company Profile
TABLE 401: Laborie Medical Technologies: Company Profile
TABLE 402: SonoScape Medical Corp.: Company Profile
TABLE 403: Clarus Medical LLC: Company Profile
TABLE 404: U.S. Endoscopes Market: Future Market Scenario Analysis, 2026–2035
TABLE 405: U.S. Endoscopes Market: Disruptive Technologies Impact Matrix
TABLE 406: U.S. Endoscopes Market: Emerging Business Trends
TABLE 407: U.S. Endoscopes Market: Business Opportunities for Startups and Existing Players
TABLE 408: U.S. Endoscopes Market: Investment Prioritization Matrix
TABLE 409: U.S. Endoscopes Market: Product White-Space Analysis
TABLE 410: U.S. Endoscopes Market: Regional Opportunity Prioritization, 2026–2035
TABLE 411: U.S. Endoscopes Market: Strategic Recommendations for Endoscope Manufacturers
TABLE 412: U.S. Endoscopes Market: Strategic Recommendations for Hospitals and Integrated Health Systems
TABLE 413: U.S. Endoscopes Market: Strategic Recommendations for Ambulatory Surgery Centers and Endoscopy Centers
TABLE 414: U.S. Endoscopes Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 415: U.S. Endoscopes Market: Strategic Recommendations for Distributors and Channel Partners
TABLE 416: U.S. Endoscopes Market: Strategic Recommendations for New Entrants and Startups
TABLE 417: U.S. Endoscopes Market: Go-to-Market Strategy Considerations
TABLE 418: U.S. Endoscopes Market: Product Positioning and Portfolio Expansion Guidance
TABLE 419: U.S. Endoscopes Market: Pricing and Contracting Recommendations
TABLE 420: U.S. Endoscopes Market: Clinical Evidence and Regulatory Strategy
TABLE 421: U.S. Endoscopes Market: Partnership, Acquisition and Licensing Opportunities
TABLE 422: U.S. Endoscopes Market: Scope Limitation
TABLE 423: U.S. Endoscopes Market: Data Use Limitation
TABLE 424: U.S. Endoscopes Market: Market Definition Limitation
TABLE 425: U.S. Endoscopes Market: Forecasting Limitation
TABLE 426: U.S. Endoscopes Market: Legal Disclaimer
TABLE 427: U.S. Endoscopes Market: Third-Party Data Disclaimer
TABLE 428: U.S. Endoscopes Market: Company and Product Information Disclaimer
TABLE 429: U.S. Endoscopes Market: Regulatory and Reimbursement Disclaimer

List of Figures

FIGURE 1: U.S. Endoscopes Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: Value Chain Analysis
FIGURE 4: Supply Chain Analysis
FIGURE 5: PESTEL Analysis
FIGURE 6: Porter’s Five Forces Analysis
FIGURE 7: Market Attractiveness Analysis
FIGURE 8: Market Dynamics
FIGURE 9: Innovation & Patent Landscape, 2021–2025
FIGURE 10: Clinical Workflow Economics Framework
FIGURE 11: Hospital Capital Procurement Decision Framework
FIGURE 12: U.S. Endoscopes Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 13: U.S. Endoscopes Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 14: U.S. Endoscopes Market Year-wise Growth Curve, 2021–2035
FIGURE 15: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 16: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 17: Flexible Endoscopes Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 18: Rigid Endoscopes Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 19: Single-Use Endoscopes Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 20: Capsule Endoscopes Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 21: Robot-Assisted and Navigation-Enabled Endoscopes Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 22: Application Segment Market Share Analysis, 2025 & 2035
FIGURE 23: Application Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 24: Gastrointestinal Endoscopy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 25: Laparoscopy and General Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Urology Endoscopy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Bronchoscopy and Pulmonary Endoscopy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Ear, Nose and Throat Endoscopy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Gynecology Endoscopy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 30: Orthopedic Endoscopy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Neuroendoscopy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Other Endoscopic Applications Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: End User Segment Market Share Analysis, 2025 & 2035
FIGURE 34: End User Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 35: Hospitals and Integrated Health Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Ambulatory Surgery Centers and Dedicated Endoscopy Centers Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Specialty Clinics and Physician Offices Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: Academic Medical Centers and Specialty Referral Institutions Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Rural Hospitals and Community Healthcare Facilities Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 40: Mobile Endoscopy and Outreach Services Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Technology Type Segment Market Share Analysis, 2025 & 2035
FIGURE 42: Technology Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 43: High-Definition and 4K Imaging Endoscopes Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 44: AI-Compatible and Computer-Assisted Endoscopy Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: Endoscopic Ultrasound-Enabled Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 46: Single-Use Digital Imaging Technology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 47: Robotic and Navigation-Assisted Technology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 48: Capsule Imaging and AI-Assisted Capsule Review Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: Procurement Channel Segment Market Share Analysis, 2025 & 2035
FIGURE 50: Procurement Channel Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: Direct Hospital and Health System Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Integrated Delivery Network Enterprise Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Group Purchasing Organization Contracts Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Distributor and Specialty Supplier Sales Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Ambulatory and Office-Based Procurement Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Digital and Direct-to-Facility Ordering for Single-Use Endoscopes Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 58: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: West Region U.S. Endoscopes Market Share and Leading Players, 2025
FIGURE 60: West Region Market Share Analysis by State, 2025
FIGURE 61: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: California Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Washington Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Arizona Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 65: Colorado Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: Oregon Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Utah Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: Nevada Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: New Mexico Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Idaho Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Montana Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Wyoming Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: Alaska Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Hawaii Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Northeast Region U.S. Endoscopes Market Share and Leading Players, 2025
FIGURE 76: Northeast Region Market Share Analysis by State, 2025
FIGURE 77: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: New York Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Massachusetts Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: New Jersey Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: Pennsylvania Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Connecticut Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: Maine Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Vermont Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: New Hampshire Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Rhode Island Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Delaware Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: South Region U.S. Endoscopes Market Share and Leading Players, 2025
FIGURE 89: South Region Market Share Analysis by State, 2025
FIGURE 90: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Texas Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: Florida Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Georgia Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 94: North Carolina Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Tennessee Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: South Carolina Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Alabama Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Mississippi Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Louisiana Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Arkansas Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Kentucky Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Oklahoma Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Virginia Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Maryland Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: West Virginia Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: Midwest Region U.S. Endoscopes Market Share and Leading Players, 2025
FIGURE 107: Midwest Region Market Share Analysis by State, 2025
FIGURE 108: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 109: Illinois Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 110: Ohio Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 111: Michigan Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 112: Minnesota Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 113: Indiana Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 114: Wisconsin Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 115: Missouri Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 116: Iowa Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 117: Kansas Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 118: Nebraska Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 119: North Dakota Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 120: South Dakota Endoscopes Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 121: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 122: Company Positioning Matrix
FIGURE 123: Key Player Product Portfolio Benchmarking
FIGURE 124: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 125: U.S. Endoscope Innovation Roadmap
FIGURE 126: AI-Assisted Endoscopy Adoption Roadmap
FIGURE 127: Single-Use Endoscope Opportunity Map
FIGURE 128: Robotic Bronchoscopy and Navigation Growth Roadmap
FIGURE 129: Endoscopic Ultrasound Technology Opportunity Map
FIGURE 130: Connected Endoscopy and Quality Analytics Roadmap
FIGURE 131: Future Market Scenario Analysis, 2026–2035
FIGURE 132: Disruptive Technologies Impact Matrix
FIGURE 133: Emerging Business Trends Matrix
FIGURE 134: Investment Prioritization Matrix
FIGURE 135: Product White-Space Opportunity Map
FIGURE 136: Strategic Growth Roadmap for U.S. Endoscope Companies
FIGURE 137: Go-to-Market Strategy Framework
FIGURE 138: Product Positioning and Portfolio Expansion Framework
FIGURE 139: Report Scope and Disclaimer Framework